Source: Zacks

Axonics: Boston Scientific Stock Set to Gain From Completion of Axonics Deal

BSX's acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.

Read full article »
Annual Revenue
$100-500M
Employees
500-1.0K
Raymond W. Cohen's photo - Co-Founder & CEO of Axonics

Co-Founder & CEO

Raymond W. Cohen

CEO Approval Rating

91/100

Read more